Increases in mast cells and chymase in fibroproliferative paws of collagen-induced arthritic mice

Inflammation Research

Volumn 48, Issue 6, 1999, Pages 318-324

  Kakizoe, E ^a   Li, S H ^a   Kobayashi, Y ^a,b   Nishikori, Y ^a   Dekio, S ^a   Okunishi, H ^a,b  

^a SHIMANE UNIVERSITY   (Japan)

^b Shimane Institute of Health Science   (Japan)

Author keywords

Arthritic mouse model; Chymase; Fibroproliferative change; Mast cells

Indexed keywords

ADJUVANT; CHROMOGENIC SUBSTRATE; CHYMASE; COLLAGEN; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EMULSION; ENZYME ACTIVITY; IMMUNIZATION; INFLAMMATION; JOINT DESTRUCTION; MALE; MAST CELL; MOUSE; NONHUMAN;

ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS, RHEUMATOID; CELL COUNT; CHYMASES; COLLAGEN; FIBROSIS; MAST CELLS; MICE; MICE, INBRED DBA; SERINE ENDOPEPTIDASES; STATISTICS, NONPARAMETRIC;

EID: 0032801224     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050467     Document Type: Article

References (34)

1. Krane SM, Simon LS. Rheumatoid arthritis: clinical features and pathogenic mechanisms. Med Clin North Am 1986; 70: 263-84.
2. TC subset with matrix turnover and clinical progression. Arthritis Rheum 1997; 40: 479-89.
3. Renoux M, Hilliquin P, Galoppin L, Florentin I, Menkes CJ. Release of mast cell mediators and nitrites into knee joint fluid in osteoarthritis comparison with articular chondrocalcinosis and rheumatoid arthritis. Osteoarthritis Cartilage 1996; 4: 175-9.
4. Tetlow LC, Woolley DE. Mast cells, cytokines, and metallo-proteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995; 54: 896-903.
5. Shiota N, Okunishi H, Fukamizu A, Sakonjo H, Kikumori M, Nishimura T, et al. Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett 1993; 323: 239-42.
6. Shiota N, Jin D, Takai S, Kawamura T, Koyama M, Nakamura N, et al. Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension. FEBS Lett 1997; 406: 301-4.
7. McEuen AR, Sharma B, Walls AF. Regulation of the activity of human chymase during storage and release from mast cells: the contributions of inorganic cations, pH, heparin and histamine. Biochim Biophys Acta 1995; 1267: 115-21.
8. 84 bond by mast cell chymase. J Biol Chem 1994; 269: 18134-40.
9. Vartio T, Seppä H, Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem 1981; 256: 471-7.
10. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995; 270: 4689-96.
11. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. New Engl J Med 1994; 331: 1286-92.
12. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem 1997; 272: 7127-31.
13. el Sayed SO, Dyson M. Responses of dermal mast cells to injury. J Anat 1993; 182: 369-76.
14. Hebda PA, Collins MA, Tharp MD. Mast cell and myofibroblast in wound healing. Dermatol Clin 1993; 11: 685-96.
15. Nishikori Y, Kakizoe E, Kobayashi Y, Shimoura K, Okunishi H, Dekio S. Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase. Arch Dermatol Res 1998; 290: 553-60.
16. Holmdahl R, Andersson M, Tarkowski A. Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes. Immunology 1987; 61: 369-74.
17. Nabozny GH, David CS. The immunogenetic basis of collagen induced arthritis in mice: an experimental model for the rational design of immunomodulatory treatments of rheumatoid arthritis. Adv Exp Med Biol 1994; 347: 55-63.
18. Li S-H, Kobayashi Y, Yamauchi Y, Gonda T, Tsunematsu T. Suppressive effects of a herbal formula, TBL-1, on type II collagen-induced arthritis in DBA/1J mice. Clin Exp Pharmacol Physiol 1996; 23: 236-40.
19. Harvima IT, Naukkarinen A, Harvima RJ, Aalto M-L, Neittaanmäki H, Horsmanheimo M. Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 1990; 282: 428-33.
20. Ebi Y, Kasugai T, Seino Y, Onoue H, Kanemoto T, Kitamura Y. Mechanism of mast cell deficiency in mutant mice of mi/mi genotype: an analysis by co-culture of mast cells and fibroblasts. Blood 1990; 75: 1247-51.
21. 2. J Immunol 1987; 139: 3431-41.
22. 2, and leukotrienes. J Immunol 1987; 139: 494-500.
23. Massague J, Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem 1993; 62: 515-41.
24. Samet JM, Fonteh AN, Galli SJ, Tsai M, Fasano MB, Chilton FH. Alterations in arachidonic acid metabolism in mouse mast cells induced to undergo maturation in vitro in response to stem cell factor. J Allergy Clin Immunol 1996; 97: 1329-41.
25. Tsai M, Shih L-S, Newlands GFJ, Takeishi T, Langley KE, Zsebo KM, et al. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 1991; 174: 125-31.
26. Levi-Schaffer F, Kupietzky A. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp Cell Res 1990; 188: 42-9.
27. Subba Rao PV, Friedman MM, Atkins FM, Metcalfe DD. Phagocytosis of mast cell granules by cultured fibroblasts. J Immunol 1983; 130: 341-9.
28. Sempowski GD, Beckmann MP, Derdak S, Phipps RP. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 1994; 152: 3606-14.
29. Walker M, Harley R, Maize J, DeLustro F, LeRoy EC. Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc Soc Exp Biol Med 1985; 180: 323-8.
30. Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, et al. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 1997; 94: 9017-21.
31. Chandrasekharan UM, Sanker S, Glynias MJ, Karnik SS, Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996; 271: 502-5.
32. Hunt JE, Friend DS, Gurish MF, Feyfant E, Sali A, Huang C, et al. Mouse mast cell protease 9, a novel member of the chromosome 14 family of serine proteases that is selectively expressed in uterine mast cells. J Biol Chem 1997; 272: 29158-66.
33. Springman EB, Serafin WE. Secretory endo- and exopeptidases of mouse mast cells: structure, genetics, and regulation of expression. In: Caughey GH, editor. Mast cell proteases in immunology and biology. New York: Marcel Dekker, 1995: 169-201.
34. Okunishi H, Oka Y, Shiota N, Kawamoto T, Song K, Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 1993; 62: 207-10.